89bio Inc (NASDAQ: ETNB) on Friday, plunged -9.82% from the previous trading day, before settling in for the closing price of $8.96. Within the past 52 weeks, ETNB’s price has moved between $5.99 and $11.84.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 42.05%. With a float of $140.33 million, this company’s outstanding shares have now reached $145.98 million.
Let’s look at the performance matrix of the company that is accounted for 93 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
89bio Inc (ETNB) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of 89bio Inc is 3.88%, while institutional ownership is 89.66%. The most recent insider transaction that took place on Jan 30 ’25, was worth 49,999,994. In this transaction Director of this company bought 5,714,285 shares at a rate of $8.75, taking the stock ownership to the 19,554,319 shares. Before that another transaction happened on Jan 22 ’25, when Company’s Director bought 10,000 for $6.71, making the entire transaction worth $67,100. This insider now owns 25,000 shares in total.
89bio Inc (ETNB) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 42.05% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 18.45% during the next five years compared to 32.21% growth over the previous five years of trading.
89bio Inc (NASDAQ: ETNB) Trading Performance Indicators
89bio Inc (ETNB) is currently performing well based on its current performance indicators. A quick ratio of 13.19 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.43, a number that is poised to hit -0.51 in the next quarter and is forecasted to reach -2.07 in one year’s time.
Technical Analysis of 89bio Inc (ETNB)
89bio Inc (NASDAQ: ETNB) saw its 5-day average volume 2.2 million, a negative change from its year-to-date volume of 2.46 million. As of the previous 9 days, the stock’s Stochastic %D was 42.32%. Additionally, its Average True Range was 0.75.
During the past 100 days, 89bio Inc’s (ETNB) raw stochastic average was set at 35.77%, which indicates a significant decrease from 49.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 105.49% in the past 14 days, which was higher than the 91.26% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.07, while its 200-day Moving Average is $8.46. Nevertheless, the first resistance level for the watch stands at $8.71 in the near term. At $9.35, the stock is likely to face the second major resistance level. The third major resistance level sits at $9.75. If the price goes on to break the first support level at $7.67, it is likely to go to the next support level at $7.27. Assuming the price breaks the second support level, the third support level stands at $6.63.
89bio Inc (NASDAQ: ETNB) Key Stats
Market capitalization of the company is 1.18 billion based on 145,984K outstanding shares. Right now, sales total 0 K and income totals -367,080 K. The company made 0 K in profit during its latest quarter, and -118,350 K in sales during its previous quarter.
